Welcome to WeedTV

I am at least 21 years old or a valid medical marijuana patient

5 Marijuana Stocks that Will Benefit From Marijuana Becoming Legal in More States

Imagine the year of 1934. Prohibition has just been ratified. Wouldn’t it have been great to have owned stocks from Anheuser-Busch back then, which over the next few decades became the largest brewer in the U.S.

Imagine the year of 1934. Prohibition has just been ratified. Wouldn’t it have been great to have owned stocks from Anheuser-Busch back then, which over the next few decades became the largest brewer in the U.S. The opportunity to own the next Anheuser-Busch or Coors of the future is here, in the fast emerging industry that is the marijuana industry.

In the past, the thought of owning marijuana stocks was a fool’s dream. Today, it is a reality. Just like with alcohol stocks after the Prohibition ended, marijuana stocks now have their watershed moment. Legalized marijuana is still new, however the industry has taken off. Even though the marijuana industry tends to experience bouts of instability, there still marijuana stocks that are well worth investing in.

The best marijuana stocks to own right now are:

GW Pharmaceuticals:(GWPH) This biotech company is headquartered in the United Kingdom and has gained a lot of attention for its marijuana based antiepileptic drug Epidiolex. As of now, the drug has experienced success with patients reporting 39% less seizures than before, which confirms the effectiveness of cannabinoids. The FDA has also given GW Pharmaceuticals a seven-year exclusive right to use Epidiolex for treatment of tuberous sclerosis complex, which is a rare disorder known to cause many cases of epilepsy. This is called ‘orphan status,” or a right given certain drugs to treat rare diseases. Another of its cannabis-based drugs, Sativex, was approved for use in the treatment of cancer and multiple sclerosis in New Zealand and in Europe. With a lot of cash on hand and virtually zero debt, GW is ready to increase investments in more research and development, which means experts predict a rise in this marijuana stock’s market value.